INFLUENCE OF TUMOR SITE ON THE THERAPY OF MURINE KIDNEY CANCER

Citation
A. Chakrabarty et al., INFLUENCE OF TUMOR SITE ON THE THERAPY OF MURINE KIDNEY CANCER, Anticancer research, 14(2A), 1994, pp. 373-378
Citations number
21
Categorie Soggetti
Oncology
Journal title
ISSN journal
02507005
Volume
14
Issue
2A
Year of publication
1994
Pages
373 - 378
Database
ISI
SICI code
0250-7005(1994)14:2A<373:IOTSOT>2.0.ZU;2-K
Abstract
Objective: The purpose of this study was to evaluate the influence of tumor site on the therapy of an epxerimental murine kidney cancer mode l, Ranca. Methods: Equal number of tumor cells were injected subcutane ously, intraperitoneally, sub-renal capsule, and in travenously to ind uce tumors. The animals were then assessed for growth of the primary t umor, metastases and survival. Immunohistochemistry and flow cytometry was performed to identify the phenotype of infiltrating lymphocytes. Tumor bearing animals were treated with high dose interleukin-2 or who le body radiation, and response of the primary tumors as well as the m etastases was assessed. Results: Renca tumors grew well regardless of the methods of induction. Spontaneous metastasis could be best induced in the sub-renal capsule model. More consistent numbers of pulmonary metastases were obtained by intravenous injection of the tumor cells. Immunotherapy was able to reduce the size of the primary tumor as well as the number of metastasis. Whole body radiation caused some reducti on in the primary tumor but did not have a major effect in reducing me tastasis. Conclusions: The Renca model is a suitable animal model to s tudy the response to different therapeutic interventions. The site of the tumor growth is not a significant variable in the response! to tre atment.